BackTable Urology
Ep. 207 Integrating Clinical Trials into Routine Urology Practice with Dr. Behfar Ehdaie
Aditya Bagrodia
Makes sense, right? I mean, you see perfect examples of that. You know, one recent one that comes into mind is the recent BRIDGE study comparing BCG versus gem dose C for non-most invasive high-risk bladder cancer. The study PI did a small pilot at their home institution. It went well. And then through the cooperative groups, we're able to get something substantial moving.
0
💬
0
Comments
Log in to comment.
There are no comments yet.